Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03630042 · MORE INFO

Limitations, agreements, and source contact

Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia · Source last updated 2024-11-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The sample size of 42 was not reached so limited conclusions can be made.
point Of Contact
email
Jaimal.Kothari@ouh.nhs.uk
organization
Oxford University Hospital NHS Trust
phone
NA
title
Jaimal Kothari
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The sample size of 42 was not reached so limited conclusions can be made.
point Of Contact
email
Jaimal.Kothari@ouh.nhs.uk
organization
Oxford University Hospital NHS Trust
phone
NA
title
Jaimal Kothari

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice